Skip to main content
OpenTrials

Clinical trial condition

Renal Insufficiency, Chronic

Explore clinical trials studying Renal Insufficiency, Chronic. Study availability and eligibility vary by location and protocol.

2,272 public trials 370 recruiting studies
Refine in advanced search Browse all conditions

Renal Insufficiency, Chronic trial results

Completed

An Extension Trial to Assess the Safety of Re-dosing of Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®)

NCT02962648

Conditions
Anemia, Anemia, Hypochromic, Anemia, Iron-Deficiency, +20 more
Locations
  • Pharmacosmos Investigational Site Chula Vista, California, United States
  • Pharmacosmos Investigational Site 1 La Mesa, California, United States
  • Pharmacosmos Investigational Site 2 La Mesa, California, United States
  • Pharmacosmos Investigational Site Northridge, California, United States
View all 22 locations
View Trial Details
Completed

Patient and Provider Assessment of Lipid Management Registry

NCT02341664

Conditions
Angina, Angina Pectoris, Angina, Unstable, +62 more
Locations
  • Cardiology and Medicine Clinic Little Rock, Arkansas, United States
  • COR Healthcare San Pedro, California, United States
  • Ventura Cardiology Consultants Medical Group, Inc Ventura, California, United States
  • Maya Research Center, Inc Hialeah, Florida, United States
View all 14 locations
View Trial Details
Completed

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Three-times Weekly Dosing of GSK1278863 in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease Who Are Switched From a Stable Dose of an Erythropoiesis-stimulating Agent

NCT02689206

Conditions
Anaemia, Anemia, Chronic Disease, +13 more
Locations
  • GSK Investigational Site Northridge, California, United States
  • GSK Investigational Site San Dimas, California, United States
  • GSK Investigational Site Pembroke Pines, Florida, United States
  • GSK Investigational Site Greenbelt, Maryland, United States
View all 38 locations
View Trial Details
Completed

A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416

NCT03283098

Conditions
Chronic Disease, Disease Attributes, Endocrine System Diseases, +14 more
Locations
  • Research Site Beijing, Beijing Municipality, China
  • Research Site Nanjing, Jiangsu, China
  • Research Site Shanghai, Shanghai Municipality, China
  • Research Site Shanghai, Shanghai Municipality, China
View Trial Details

Related conditions